MLNT

Melinta Therapeutics (MLNT)

Melinta Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MLNT

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/06/25	05:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Termination of Merger Agreement and Tender Offer for Shares of Tetraphase	NASDAQ:MLNT	Melinta Therapeutics Inc
2020/06/10	05:02	GlobeNewswire Inc.	Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals	NASDAQ:MLNT	Melinta Therapeutics Inc
2020/03/05	06:03	GlobeNewswire Inc.	Melinta Therapeutics Confirms Deerfield as Successful Bidder for Company	NASDAQ:MLNT	Melinta Therapeutics Inc
2020/02/14	06:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Court Approval of Chapter 11 Bidding Procedures	NASDAQ:MLNT	Melinta Therapeutics Inc
2020/02/06	01:15	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:MLNT	Melinta Therapeutics Inc
2020/01/09	06:39	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/12/27	23:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/12/27	23:02	GlobeNewswire Inc.	Melinta Therapeutics Announces Restructuring Support Agreement with its Secured Lenders under its Senior Credit Facility	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/11/13	07:07	GlobeNewswire Inc.	Melinta Therapeutics Files Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/11/13	07:00	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/11/07	07:27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/10/26	01:54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/10/26	01:53	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/10/25	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/10/25	05:02	GlobeNewswire Inc.	Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Tr...	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/10/01	23:07	PR Newswire (US)	Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/09/14	04:00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/09/04	05:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/09/04	05:05	GlobeNewswire Inc.	Melinta Therapeutics Announces Appointment of Jennifer Sanfilippo to Interim Chief Executive Officer and Director	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/13	19:02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/09	20:41	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/09	20:38	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/09	20:31	GlobeNewswire Inc.	Melinta Therapeutics Names David Gill as Chairman and Announces CEO Succession Plan	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/09	20:30	GlobeNewswire Inc.	Melinta Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/08/07	06:04	GlobeNewswire Inc.	Melinta Therapeutics Announces Rescheduling of Second Quarter 2019 Financial Results Reporting	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/07/17	05:51	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/07/16	20:30	GlobeNewswire Inc.	Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/07/11	04:00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/07/03	06:23	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:MLNT	Melinta Therapeutics Inc
2019/07/02	06:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:MLNT	Melinta Therapeutics Inc